According to our (Global Info Research) latest study, the global Deferiprone market size was valued at US$ 39.6 million in 2024 and is forecast to a readjusted size of USD 49.3 million by 2031 with a CAGR of 3.2% during review period.
Deferiprone is an orally bioavailable bidentate ligand with iron chelating activity.1 It binds to iron in a 3:1 (ligand:iron) molar ratio and, thereby, is able to remove excess iron from the body. Deferiprone has been investigated for clinical use in diseases of systemic iron overload.
Apotex, Cipla and other company are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry. Those two totally got about 96% market shares.
North America is the largest consumption region of Deferiprone, with a consumption value market share nearly 28%. Europe is the second largest consumption region of deferiprone, enjoying consumption value market share nearly 24%.
This report is a detailed and comprehensive analysis for global Deferiprone market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Deferiprone market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/g), 2020-2031
Global Deferiprone market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/g), 2020-2031
Global Deferiprone market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/g), 2020-2031
Global Deferiprone market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (USD/g), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Deferiprone
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Deferiprone market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Apotex, Cipla, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Deferiprone market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Tablet
Oral Solution
Capsule
Market segment by Application
Transfusional Iron Overload
NTDT Caused Iron Overload
Major players covered
Apotex
Cipla
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Deferiprone product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Deferiprone, with price, sales quantity, revenue, and global market share of Deferiprone from 2020 to 2025.
Chapter 3, the Deferiprone competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Deferiprone breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Deferiprone market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Deferiprone.
Chapter 14 and 15, to describe Deferiprone sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Deferiprone. Industry analysis & Market Report on Deferiprone is a syndicated market report, published as Global Deferiprone Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Deferiprone market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.